Skip to main content

. 1990 Jul;43(7):610. doi: 10.1136/jcp.43.7.610-a

Selective medium for isolating Arcanobacterium haemolyticum.

N P Brenwald, E L Teare, L K Mountfort, R E Tettmar

PMCID: PMC502596 PMID: 2380412

610

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Banck G., Nyman M. Tonsillitis and rash associated with Corynebacterium haemolyticum. J Infect Dis. 1986 Dec;154(6):1037–1040. doi: 10.1093/infdis/154.6.1037. [DOI] [PubMed] [Google Scholar]
Järvinen H., Nissinen A., Huovinen P. Erythromycin resistance in group A streptococci. Lancet. 1989 May 6;1(8645):1022–1023. doi: 10.1016/s0140-6736(89)92667-6. [DOI] [PubMed] [Google Scholar]
Selander B., Ljungh A. Corynebacterium haemolyticum as a cause of nonstreptococcal pharyngitis. J Infect Dis. 1986 Dec;154(6):1041–1041. doi: 10.1093/infdis/154.6.1041. [DOI] [PubMed] [Google Scholar]
Sutherland R., Boon R. J., Griffin K. E., Masters P. J., Slocombe B., White A. R. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother. 1985 Apr;27(4):495–498. doi: 10.1128/aac.27.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES